Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03373279 · ClinicalTrials.gov registry record
Bioelectrical Impedance Spectroscopy in Heart Transplantation: Tracking Post-Transplant Changes in Body Composition and Correlation With Conventional Preoperative Risk Assessment Modalities
A clinical trial of Heart Transplant Failure and Rejection, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 69
- Enrollment target
- 1
- Study location
NCT03373279 is a study of Heart Transplant Failure and Rejection that has completed, run by Baylor Research Institute. The registered enrollment target is 69 participants, below the 197-participant average among 5 other Heart Transplant Failure and Rejection trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03373279, a study of Heart Transplant Failure and Rejection, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 69 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with marginal physiologic reserve, severe frailty, and/or malnutrition may be regarded as unsuitable candidates for advanced cardiac replacement therapies. However, little data exist on precisely which measures are predictive of subsequent adverse events. Assessment of nutritional status and frailty is still largely predicated on crude and obsolete parameters, such as baseline serum albumin level or body mass index (BMI). In this prospective cohort study the investigators will evaluate the use of bio-electrical impedance spectroscopy (BIS) as a measure of body composition and assess the associations with surgical outcomes.
Conditions Studied
Study Locations (1)
Texas
- Baylor University Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2023-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03373279
The ClinicalTrials.gov registry entry for NCT03373279 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 197-participant average among 5 other Heart Transplant Failure and Rejection trials with a reported enrollment target (65% lower). The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Transplant Failure and Rejection appearing as the primary indexed condition, and to 0 interventions.
NCT03373279 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03373279 about?
NCT03373279 is a clinical study titled "Bioelectrical Impedance Spectroscopy in Heart Transplantation: Tracking Post-Transplant Changes in Body Composition and Correlation With Conventional Preoperative Risk Assessment Modalities". Patients with marginal physiologic reserve, severe frailty, and/or malnutrition may be regarded as unsuitable candidates for advanced cardiac replacement therapies. However, little data exist on precisely which measures are predictive of subsequent adverse events. Assessment of nutritional status an...
What is the current status of trial NCT03373279?
This trial is currently completed. The enrollment target is 69 participants. The study started on 2017-02-01. Estimated completion is 2023-12-30.
What conditions does trial NCT03373279 study?
This clinical trial studies the following conditions: Heart Transplant Failure and Rejection.
Who is sponsoring clinical trial NCT03373279?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03373279 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Transplant Failure and Rejection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Allograft Dysfunction in Heart Transplant
RECRUITING · Phase 4
-
Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
RECRUITING · Phase 2
-
HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection
ACTIVE NOT RECRUITING
-
A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy
ACTIVE NOT RECRUITING · NA
-
Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.